Consumeradvocates say the proposed changes will make drugs unaffordable formany people with serious medical conditions like cancer andmultiple sclerosis who rely on pricey medications. (Photo:Shutterstock)
Patients who get financial help from drug companies to covertheir copayments for prescription drugs could owe a bigger chunk oftheir costs under a proposed federal rule.
The annual rule, which sets a wide range of standards regarding benefits and payments formost health plans for next year, would allow employers and insurersto decide that drug companies' assistance doesn't count towardtheir members' deductible or out-of-pocket maximum spending limits.Only payments made by patients themselves would factor into thosecalculations.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
